Global health challenges can be resolved using digital technology: Dr Alain Labrique

Pfizer and BioNTech receive positive CHMP opinion for Omicron XBB.1.5-adapted COVID-19 vaccine

The updated COVID-19 vaccine is tailored to the Omicron XBB.1.5 sublineage of SARS-CoV-2 and is recommended for individuals 6 months of age and older

Briefs: Concord Biotech, Cian Healthcare and Eris Lifesciences

Eris Lifesciences enters into term loan agreement with Citi Bank

BioNTech appointing James Ryan as Chief Legal Officer

Ryan has nearly 20 years of global legal and IP expertise in the pharmaceutical industry

Dimensionless Technologies launches AushadhAI to support pharma supply chain

AushadhAI is purposefully designed to deliver significant advantages to the pharmaceutical supply chain's key constituents

India is set to become the global hub of medical technology and devices: Dr Mandaviya

The medical device sector is considered as one of the sunrise sectors in the country

Sartorius Bioreactors integrate Emerson Technology to speed new therapies to market

DeltaV control system natively integrated into Sartorius Biostat STR bioreactors provide a foundation for semi-autonomous operations and up to 80% less integration time

Supriya Lifescience collaborates with Plasma Nutrition for protein technology

The primary purpose of this collaboration is to bring the optimized protein into the Indian market

Thyrocare Technologies posts Q1 FY24 PAT at Rs. 17.30 Cr

The company has reported total income of Rs. 135.87 crores during the period ended June 30, 2023

Concord Biotech’s IPO to open on 4th August, 2023

The company through its IPO will fetch Rs 1475.26 crore - Rs 1550.59 crore at the lower and upper end of the price band.